Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
McKinsey
Boehringer Ingelheim
Medtronic
Merck

Last Updated: June 26, 2022

Investigational Drug Information for Tofisopam


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Tofisopam?

Tofisopam is an investigational drug.

There have been 3 clinical trials for Tofisopam. The most recent clinical trial was a Phase 2 trial, which was initiated on May 28th 2018.

The most common disease conditions in clinical trials are Dyslipidemias, Hyperuricemia, and Gout. The leading clinical trial sponsors are Pharmos, Instituto Nacional de Salud Publica, Mexico, and Laboratorios Grossman, S.A.

Recent Clinical Trials for Tofisopam
TitleSponsorPhase
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican PopulationInstituto Nacional de Salud Publica, MexicoPhase 3
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican PopulationLaboratorios Grossman, S.A.Phase 3
Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and GoutPharmosPhase 2

See all Tofisopam clinical trials

Clinical Trial Summary for Tofisopam

Top disease conditions for Tofisopam
Top clinical trial sponsors for Tofisopam

See all Tofisopam clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
McKinsey
Boehringer Ingelheim
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.